Summary: A major new analysis shows that depression substantially raises the likelihood of developing dementia whether it begins in midlife or later life. Researchers combined and re-analysed data from multiple studies to determine how the timing of depression affects later dementia risk.
The results indicate that depression in later life may not only increase risk but could sometimes reflect an early stage of dementia. These findings highlight the importance of prioritising mental health throughout life as part of efforts to preserve brain health and reduce dementia incidence.
Key Facts:
- Lifelong Risk: Depression during midlife and in later life is associated with a higher risk of developing dementia.
- Possible Early Warning: Depression that appears in late life may in some cases be an early manifestation of neurodegenerative disease rather than only a long-term risk factor.
- Public Health Priority: Integrating effective mental health care into dementia prevention strategies could reduce future dementia burden.
Source: University of Nottingham
New analysis links depression to increased dementia risk across the life course.
Published in eClinicalMedicine, this study was led by Jacob Brain and Maha Alshahrani from the Institute of Mental Health and School of Medicine at the University of Nottingham, with collaborators at the University of Adelaide and the Dementia Centre of Excellence at Curtin University in Australia.
Lead author Jacob Brain commented: “Our analysis shows a clear association between depression and later dementia risk whether depressive symptoms begin in midlife or in later decades. Recognising and treating depression at all ages is important not only for mental well‑being but also for long‑term brain health.”
He added: “Public health strategies should prioritise preventive brain health and expand access to effective mental health care, especially for groups at higher risk of dementia.”
Dementia affects more than 57 million people worldwide and currently has no cure. Identifying modifiable contributors such as depression is therefore a public health priority for reducing future disease burden.
The biological and behavioural links between depression and dementia are complex. Possible mechanisms include chronic inflammation, dysregulation of the hypothalamic–pituitary–adrenal axis, vascular changes, alterations in neurotrophic factors and neurotransmitter systems, as well as shared genetic and lifestyle factors that together may elevate dementia risk.
Past research consistently found that people with a history of depression have a greater chance of developing dementia, but uncertainty remained about whether timing matters more—depression beginning in the 40s–50s (midlife) or depression emerging in the 60s and beyond (late life).
To address this, the team conducted an umbrella review and meta-analysis. They first identified and assessed systematic reviews with meta-analyses that examined depression and incident dementia. Then they extracted and re-analysed data from the individual studies within those reviews and included more recent studies that earlier reviews had missed.
“We focused specifically on when depression was measured—midlife versus later life—and calculated how much it raised the risk of all‑cause dementia,” said Mr Brain. “This approach gives a more precise, up‑to‑date picture of how depression at different life stages relates to dementia risk.”
About this depression and dementia research news
Author: Charlotte Wall
Source: University of Nottingham
Contact: Charlotte Wall – University of Nottingham
Image: The image is credited to Neuroscience News
Original Research: Open access. “Temporal dynamics in the association between depression and dementia: an umbrella review and meta-analysis” by Jacob Brain et al., eClinicalMedicine
Abstract
Temporal dynamics in the association between depression and dementia: an umbrella review and meta-analysis
Background
Reducing dementia incidence depends on identifying modifiable risk factors across the life course. Depression is widely considered one such factor, but how its timing influences dementia risk has been unclear. This study aimed to systematically evaluate whether depression measured in midlife or later life predicts all‑cause late‑life dementia.
Methods
The researchers performed an umbrella review and meta-analysis of systematic reviews with meta-analyses and then re‑analysed data from individual cohort studies reporting hazard ratios for incident dementia. Databases searched included PubMed, Ovid Embase, MEDLINE and PsycInfo up to February 17, 2025. The review is registered with PROSPERO (CRD42021249706).
Findings
From 7,763 records, nine reviews met inclusion criteria for the umbrella review; one review was rated moderate quality and the remainder were low or critically low. For meta-analysis, the team included 18 studies where depression onset was measured in later life (total n ≈ 901,762; 7,595 incident dementia cases) and seven studies where depression was assessed in midlife (total n ≥ 2,501,269; ≥ 276,929 incident dementia cases).
All included cohort studies were judged to be of good quality, with no strong evidence of publication bias. Pooled hazard ratios showed that late‑life depression nearly doubled the risk of all‑cause dementia (HR 1.95, 95% CI: 1.68–2.26), while midlife depression increased risk by a substantial but smaller margin (HR 1.56, 95% CI: 1.12–2.18). Heterogeneity across studies was substantial and should be considered when interpreting effect sizes.
Interpretation
The results support the conclusion that depression across the life span is associated with elevated dementia risk. The stronger link observed for late‑life depression could reflect depression acting as an early symptom of neurodegenerative disease in some individuals, as well as an independent risk factor.
A life‑course approach to preventing and treating depression, alongside expanded access to effective mental health services, may help reduce future dementia burden. Additional research is needed to disentangle whether late‑life depression predominantly signals imminent neurodegeneration or contributes directly to long‑term risk.
Funding
National Institute for Health and Care Research, UK Research and Innovation, and the Saudi Arabian Cultural Mission.